Insider Trading March 17, 2026

Bel Fuse VP Disposes $112,171 in Class B Shares as Stock Climbs; Firm Posts Better-Than-Expected Quarter

Transaction by Asia operations vice president comes amid double-digit revenue growth and an analyst price-target upgrade tied to aerospace and commercial demand

By Leila Farooq BELFB
Bel Fuse VP Disposes $112,171 in Class B Shares as Stock Climbs; Firm Posts Better-Than-Expected Quarter
BELFB

Kenneth Koon Keung Lai, Bel Fuse's vice president of Asia operations, sold 552 shares of Class B common stock on March 16, 2026, generating $112,171. After the trade Lai holds 7,532 shares. The disposal occurred as Bel Fuse shares traded near $209.52, up about 173% over the past year. The company also reported fourth-quarter results that topped analyst forecasts and prompted Needham to raise its price target to $250 while keeping a Buy rating.

Key Points

  • Kenneth Koon Keung Lai sold 552 Class B shares on March 16, 2026, at $203.21 per share, totaling $112171; he now directly owns 7,532 shares.
  • Bel Fuse reported fourth-quarter results that beat analyst estimates, with sales up 17% year-over-year versus an expected 15% increase.
  • Needham raised its price target to $250 and maintained a Buy rating, citing strength in aerospace and defense and recovering demand in commercial networking and commercial aerospace.

Kenneth Koon Keung Lai, who serves as vice president of Asia operations at Bel Fuse (NASDAQ:BELFB), completed a sale of 552 shares of the company’s Class B common stock on March 16, 2026. The shares transacted at $203.21 apiece, producing proceeds of $112171. Following the disposition, Lai is recorded as directly owning 7,532 shares of Bel Fuse.

The transaction occurred while the stock was trading at $209.52, a level that represents a 173% increase in the share price over the last 12 months. Separately, filings show that on March 15, 2026, Lai acquired 329 shares of Class B common stock that are reported with a value of $0.


Bel Fuse’s latest operational and financial context helps explain recent market attention. The company released fourth-quarter results that exceeded analysts’ expectations, with revenues, gross margins, and earnings per share all coming in above projections. Sales climbed 17% year-over-year, surpassing the previously anticipated 15% expansion.

In response to those results, Needham raised its price target for Bel Fuse to $250 and reiterated a Buy rating. Needham’s revision follows an earlier uplift of its target from $168 to $212 and was framed around strength in the aerospace and defense markets as a key driver of the improved outlook. The firm also cited recovering demand in the company’s commercial segments, including networking and commercial aerospace, as contributing to the more optimistic view.

Market-value context and third-party analysis are also highlighted in available data. InvestingPro reports that the stock presently appears overvalued relative to its Fair Value and notes there are 14 additional ProTips available to subscribers.


The publicly filed transactions and the firm’s quarterly performance together provide contemporaneous signals about insider activity, market pricing, and analyst sentiment. The reporting shows both an insider sale and a separate small acquisition entry, alongside corporate results that outpaced expectations and prompted analyst price-target increases tied to sector demand dynamics.

Readings on valuation from InvestingPro are explicitly noted as indicating overvaluation versus Fair Value, while Needham’s commentary links Bel Fuse’s trajectory to performance in aerospace and defense as well as recovery in commercial markets.

Risks

  • InvestingPro analysis indicates the stock appears overvalued relative to its Fair Value, presenting valuation risk to investors - impacts equity markets and valuation-sensitive sectors.
  • The company’s improved outlook and recent analyst upgrades are linked to performance in aerospace and defense and recovering commercial demand; this ties Bel Fuse’s prospects to those sectors' health.
  • A March 15, 2026 acquisition of 329 Class B shares is recorded with a value of $0, an anomaly in the filings that represents an uncertainty in the reported transaction details.

More from Insider Trading

Amplify Energy Director Sells Nearly 1 Million Shares as Company Executes Financial Moves Mar 17, 2026 Neurogene Chief Scientific Officer Disposes of $141K in Shares; Company Advances NGN-401 Program Mar 17, 2026 Grocery Outlet Officer Sells $22,452 in Stock as Company Grapples with Softening Metrics Mar 17, 2026 Grocery Outlet Director Increases Stake with $702,617 in Purchases Mar 17, 2026 Harvard Bioscience CEO Buys $25,050 of Stock as Company Posts Mixed Q4 Results and Sets 2026 Targets Mar 17, 2026